Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07089823
PHASE1

A Study of YP05002 in Healthy Participants

Sponsor: Yaopharma Co., Ltd.

View on ClinicalTrials.gov

Summary

This is a phase I, randomized, double-blind, placebo-controlled, single and multiple ascending dose study to evaluate the safety, tolerability, pharmacokinetics, efficacy, food effect of YP05002 Tablets in healthy participants

Official title: A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of YP05002 in Healthy Participants

Key Details

Gender

All

Age Range

18 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

76

Start Date

2025-08-19

Completion Date

2026-06-30

Last Updated

2025-08-06

Healthy Volunteers

Yes

Interventions

DRUG

YP05002

Tablet, QD

OTHER

Placebo

Tablet, QD

Locations (1)

Nucleus Network Melbourne Clinic

Melbourne, Victoria, Australia